Barry James exercised Options covering 2,083 BIO-RAD LABORATORIES shares at $0 per share, leaving him with 2,495 shares. Investors can also see a 4,313-derivative-security award and a resulting 2,112 derivative-securities holding, with the award representing 100.0% of that post-award balance.

Key Highlights

  • A Sep. 4 award gave Barry James 4,313 derivative securities, representing about 100.0% of his resulting derivative-securities holding.
  • James held 2,112 derivative securities after exercising the options.
  • The transactions carried SEC codes M, A and F, covering option exercises, an award and reported forfeitures.

BIO-RAD LABORATORIES, INC. (NYSE: BIO) executive Barry James exercised options covering 2,083 shares at $0 per share in transactions dated Sep. 5 and Sep. 6, leaving him with 2,495 shares. James is the company’s EVP and president of LSG, and the reported activity also involved his derivative-securities holdings.

Reported Option Exercises and Holdings

A Sep. 4 award gave James 4,313 derivative securities. His resulting holding after that award was also 4,313 derivative securities, meaning the award represented about 100.0% of the resulting balance. James subsequently exercised options covering 2,083 derivative securities in transactions dated Sep. 5 and Sep. 6 at $0 per share. His derivative-securities holding after those exercises stood at 2,112. The transactions carried code M, which identifies an option exercise. Code A identifies an award, while code F identifies the reported forfeitures. The reported holdings of 2,495 shares and 2,112 derivative securities are separate post-transaction positions. Barry James’s activity therefore covered both common shares and derivative securities of BIO-RAD LABORATORIES, INC.